Anti-Factor Xa–Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort - The Journal of Pediatrics
Heparin Therapy Monitoring
Anti-Xa versus aPTT Monitoring for Intravenous Heparin Administration…
Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations | Semantic Scholar
Limitations on point care APTT for monitoring of unfractionated heparin in intensive care patients - Thrombosis Research
Unfractionated heparin (UFH), LMWH, fondaparinux, argatroban, and bivalirudin - EMCrit Project
Anticoagulation
A Review of Unfractionated Heparin and Its Monitoring
Main advantages and disadvantages of unfractionated heparin and low... | Download Scientific Diagram
Director, Vascular Medicine - ppt video online download
Unfractionated heparin (UFH), LMWH, fondaparinux, argatroban, and bivalirudin - EMCrit Project
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety - CHEST
Heparin - Unfractionated Heparin (UFH) vs Low-Molecular-Weight ... | GrepMed
Accuracy, reproducibility and costs of different laboratory assays for the monitoring of unfractionated heparin in clinical practice: a prospective evaluation study and survey among Swiss institutions | BMJ Open
Guide to Anticoagulant Therapy: Heparin | Circulation
ABC Advanced Bleeding Care Drug-Induced Bleeding Christian von Heymann. - ppt download
Laboratory tests for heparin monitoring in clinical practice: time and cost | Download Table
Examination of Laboratory for Monitoring Heparin Anticoagulant Therapy | IntechOpen
BLOOD RESEARCH
Table 1 from Monitoring unfractionated heparin with the aPTT: time for a fresh look. | Semantic Scholar
Should we abandon the APTT for monitoring unfractionated heparin? - Thrombosis Research
How to Monitor Heparin Therapy: Still a Controversy - YouTube
